Patent · US Active

Method of treating eosinophilia by administering an immunomodulating peptide

US9315544B2 · kind B2 · utility

2Cited by
1References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 10, 2013
Grant dateApr 19, 2016
Priority date
Expiry dateSep 10, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y301/27
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of treating or preventing inflammatory related diseases in a subject in need thereof comprising administering to said subject a pharmaceutically effective amount of a composition comprising an immune modulating polypeptide of SEQ ID NO: 1 is provided. A method for inhibiting cancer metastasis or growth of tumor in a subject in need thereof, comprising administering to the subject a pharmaceutically effective amount of a composition comprising an immune modulating polypeptide of SEQ ID NO: 1 is also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.